3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
5
Polycystic Ovary Syndrome
3
Neoplasms
3
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Venous Thromboembolism
1
Tuberous Sclerosis
1
Thrombosis
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Perioperative Inflammatory Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Margins of Excision
1
Lymphangioleiomyomatosis
1
Interventions
Fluorouracil
4
Oxaliplatin
3
Leucovorin
3
Irinotecan
3
Bevacizumab
3
5,10-methylenetetrahydrofolic acid
3
Colonoscopy
2
Capecitabine
2
Bisacodyl
2
trametinib
1
spartalizumab
1
pralsetinib
1
nazartinib
1
napabucasin
1
guadecitabine
1
canakinumab
1
Ursodeoxycholic Acid
1
Tinzaparin
1
Suction
1
Simvastatin
1
Radiotherapy
1
Polyethylene Glycols
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Mass Screening
1
Levoleucovorin
1
Drainage
1
Cyclophosphamide
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Intestinal Neoplasms
×
Simvastatin
×
Clear all
NCT00994903
2013-12-02
StatCol
University of Auckland, New Zealand
Phase 3
Completed
132 enrolled